Osteoarthritis Trial, Recruiting NCT06040827 Sponsor: Canary Medical Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06040827
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People whose doctor has determined they are a suitable candidate for a total knee replacement based on a physical examination and medical history, including a diagnosis of severe knee pain and difficulty moving due to osteoarthritis
  • People who have a mild or moderate knee deformity (either inward, outward, or bending-related) (confirm with trial site)
  • People who are willing and able to attend all required follow-up appointments as outlined in the trial plan
  • People whose surgeon has determined they need a specific size of tibial stem extension (58mm or 30mm) as part of their knee implant (confirm with trial site)
  • People who have gone through the trial's informed consent process and are willing to sign and date the required consent form
  • People who have a personal computer at home with wireless internet access and a USB port
  • People who, regardless of the trial, would already be considered a candidate for the Persona Personalized Knee System implant as it is commercially available

Who may not be able to join:

  • People having both knees replaced at the same time
  • People planning to have the second knee replaced within 6 months of the first procedure covered by this trial
  • People who currently misuse alcohol or drugs
  • People who are pregnant, breastfeeding, or belong to a protected group such as prisoners or those deemed legally unable to make their own decisions
  • People who have a psychiatric illness or cognitive difficulty that would prevent them from giving proper informed consent or completing follow-up
  • People who have had a previous infection in the affected knee joint, or currently have a local or widespread infection that could affect a joint implant
  • People with mental or neurological conditions that would prevent them from following post-surgery care instructions
  • People whose bones are not yet fully developed
  • People who do not have enough healthy bone in the knee area to support an implant
  • People who have a condition called Neuropathic Arthropathy, which involves joint damage related to nerve problems
  • People who have osteoporosis, significant muscle loss, or a neuromuscular disease affecting the leg being treated
  • People who have severe joint instability due to damaged or absent ligaments on the sides of the knee
  • People who have a knee that has already been surgically fused in a stable, pain-free, and functional position
  • People who have rheumatoid arthritis along with skin ulcers or a history of recurring skin breakdown
  • People who have a known or suspected allergy or sensitivity to any of the materials used in the implant
  • People currently undergoing any treatment or procedure that involves ionizing radiation (such as certain cancer treatments)
  • People who have known, symptomatic problems with their foot, hip, or spine that could affect the way they walk

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 7604976115

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Canary Medical
Registry
ClinicalTrials.gov
Start date
12 September 2023
Est. completion
1 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Safety - Adverse Events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov